Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
February 24, 2021
Oslo Cancer Cluster

Fundraising on the school curriculum

Fundraising on the school curriculum

The students of entrepreneurship at Ullern Upper Secondary School listened to Øyvind Kongstun Arnesen, former CEO of Ultimovacs, give advice about fundraising. Photo: Elisabeth Kirkeng Andersen

This article was first published in Norwegian on our School Collaboration website.

To set up a company, you need financing. In February, fundraising was a topic on the schedule for the students of entrepreneurship at Ullern Upper Secondary School. The lecturer was Øyvind Kongstun Arnesen who – as former CEO for Ultimovacs – has been through several fundraising rounds.

“Today, I will share my experiences with you and you can interrupt or ask questions as much as you like,” Øyvind Kongstun Arnesen began his lecture.

Kongstun Arnesen has 10 years of experience as CEO for Ultimovacs, a company that develops a universal cancer vaccine and has been through many rounds of raising funds.

Kongstun Arnesen shared his experiences with the students about what things companies need to organise before actively seeking financing.

“It is very important to have solid patents, which is the basis for any pharmaceutical or biotech company,” said Kongstun Arnesen.

He also stressed the importance of creating good investor presentations based on what kind of information the potential investors need.

Then, the former CEO explained the different stages of fundraising that the company had been through.

Kongstun Arnesen talks to the students of entrepreneurship at Ullern Upper Secondary School.

Kongstun Arnesen talks to the students of entrepreneurship at Ullern Upper Secondary School. Photo: Elisabeth Kirkeng Andersen

From flying start to stock market

“In the beginning, we were lucky, because one of Norway’s wealthiest men, Bjørn Rune Gjelsten, invested in the company and was also involved in the management. The reason for this was that his father was diagnosed with prostate cancer and he wished to contribute to something more than a donation to the Radium Hospital,” said Kongstun Arnesen.

Kongstun Arnesen continued to explain that having Gjelsten on the team was important for the next time the company needed to raise funds.

“Gjelsten contacted his network and we got large owners onboard, such as Canica led by Stein-Erik Hagen and others. It went surprisingly well,” said Kongstun Arnesen.

Then the company needed to go on the financial market to raise funds. The financial market consists of companies that are set up to earn money from investments. The only thing they have in common is that the companies are different and invest in differing ways.

“It is about

Last updated:
February 24, 2021

Oslo Cancer Cluster

Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines. We are a national non-profit member organisation with about 90 members.

Click here to read more about us!
Get in touch with us!
Visit us

Oslo Cancer Cluster
Ullernchausséen 64
0379 Oslo

Send us mail
The students of entrepreneurship at Ullern Upper Secondary School listened to Øyvind Kongstun Arnesen, former CEO of Ultimovacs, give advice about fundraising. Photo: Elisabeth Kirkeng Andersen

This article was first published in Norwegian on our School Collaboration website.

To set up a company, you need financing. In February, fundraising was a topic on the schedule for the students of entrepreneurship at Ullern Upper Secondary School. The lecturer was Øyvind Kongstun Arnesen who – as former CEO for Ultimovacs – has been through several fundraising rounds.

“Today, I will share my experiences with you and you can interrupt or ask questions as much as you like,” Øyvind Kongstun Arnesen began his lecture.

Kongstun Arnesen has 10 years of experience as CEO for Ultimovacs, a company that develops a universal cancer vaccine and has been through many rounds of raising funds.

Kongstun Arnesen shared his experiences with the students about what things companies need to organise before actively seeking financing.

“It is very important to have solid patents, which is the basis for any pharmaceutical or biotech company,” said Kongstun Arnesen.

He also stressed the importance of creating good investor presentations based on what kind of information the potential investors need.

Then, the former CEO explained the different stages of fundraising that the company had been through.

Kongstun Arnesen talks to the students of entrepreneurship at Ullern Upper Secondary School.

Kongstun Arnesen talks to the students of entrepreneurship at Ullern Upper Secondary School. Photo: Elisabeth Kirkeng Andersen

From flying start to stock market

“In the beginning, we were lucky, because one of Norway’s wealthiest men, Bjørn Rune Gjelsten, invested in the company and was also involved in the management. The reason for this was that his father was diagnosed with prostate cancer and he wished to contribute to something more than a donation to the Radium Hospital,” said Kongstun Arnesen.

Kongstun Arnesen continued to explain that having Gjelsten on the team was important for the next time the company needed to raise funds.

“Gjelsten contacted his network and we got large owners onboard, such as Canica led by Stein-Erik Hagen and others. It went surprisingly well,” said Kongstun Arnesen.

Then the company needed to go on the financial market to raise funds. The financial market consists of companies that are set up to earn money from investments. The only thing they have in common is that the companies are different and invest in differing ways.

“It is about

Last updated:
February 24, 2021

Oslo Cancer Cluster

Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines. We are a national non-profit member organisation with about 90 members.

Click here to read more about us!
Get in touch with us!
Visit us

Oslo Cancer Cluster
Ullernchausséen 64
0379 Oslo

Send us mail